Red Cross Draws $16.2M In FDA Blood Safety Fines

Law360, New York (June 17, 2010, 6:54 PM EDT) -- The American Red Cross has been slapped with $16.2 million in fines by the U.S. Food and Drug Administration over alleged failures to abide by laws and regulations covering blood products like red cells, plasma and platelets, the agency announced Thursday.

The fines totaled $16.18 million, which included $9.79 million for alleged blood product mismanagement violations and $6.39 million for alleged good manufacturing practices violations, according to the FDA.

The fines stem from a consent decree that was amended in 2003, and the Red Cross had...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.